Generic Semaglutide hits India: Prices fall 90% as companies compete for diabetic patients

Multiple domestic pharmaceutical companies launched generic semaglutide on Saturday, a day after the drug's patent expired in India, with prices falling by as much as 90% from the branded version, device formats ranging from reusable pens t
Read more...